Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trialTracy Stockley, Philippe L. Bédard|Genome Medicine|2016Cited by 283
Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung CancerMiguel García-Pardo, Natasha B. Leighl, Kasia Czarnecka‐Kujawa et al.|JAMA Network Open|2023Cited by 60
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsyMiguel García-Pardo, Natasha B. Leighl, Kasia Czarnecka et al.|Therapeutic Advances in Medical Oncology|2022Cited by 22
Comprehensive genomic profiling of treatment resistant metastatic castrate sensitive prostate cancer reveals high frequency of potential therapeutic targetsCoralea Kappel, Srikala S. Sridhar, Adrian G. Sacher et al.|Clinical Genitourinary Cancer|2022Cited by 3